GOLDMAN SACHS GROUP INC - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 58 filers reported holding AKCEA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,334,000
-43.6%
73,522
-57.5%
0.00%
Q2 2020$2,367,000
-11.3%
172,797
-7.4%
0.00%
Q1 2020$2,668,000
+8.2%
186,565
+28.2%
0.00%
Q4 2019$2,465,000
+150.8%
145,544
+127.8%
0.00%
Q3 2019$983,000
-18.2%
63,893
+24.6%
0.00%
Q2 2019$1,202,000
-18.5%
51,272
-1.5%
0.00%
Q1 2019$1,474,000
-3.3%
52,037
+2.9%
0.00%
Q4 2018$1,525,000
-7.0%
50,567
+8.0%
0.00%
Q3 2018$1,640,000
+7.9%
46,833
-26.9%
0.00%
Q2 2018$1,520,000
+35.6%
64,103
+46.4%
0.00%
Q1 2018$1,121,000
+87.5%
43,777
+27.0%
0.00%
Q4 2017$598,00034,4630.00%
Other shareholders

There were no reported owners of AKCEA THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of AKCEA THERAPEUTICS INC shareholders